LinkedIn·Tuesday, 11 August 2026·15d ago

Regulatory advice can change the development strategy while the organisation continues using materials built around the old one. 📄…

Vivanti

1,004 followers

Regulatory advice can change the development strategy while the organisation continues using materials built around the old one. 📄 European Medicines Agency's July stakeholder platform covered agile scientific advice, model-informed drug development, combination products and evolving development-support routes. It also included an update on the model-informed drug-development scientific-advice pilot. The opportunity to engage regulators earlier and around increasingly complex development questions is growing. That creates a downstream challenge. A recommendation may change the development assumption, evidence plan or proposed route. The meeting minutes are updated. The decision log is updated. The rest of the organisation may not update with the same discipline. Clinical-development content may continue to use the earlier rationale. Internal training may still explain the previous evidence strategy. Manufacturing teams may not see the operational implication. Medical teams may begin preparing a scientific narrative that assumes the question is closed. Market Access may recognise that the regulatory answer still leaves a payer evidence gap. 🧬 The difficult part is not recording what the regulator said. It is translating that response into the content, learning and decision support each function now needs. That translation should identify: What changed?Which assumptions are no longer valid? Which materials or programmes depend on them? What remains uncertain? Who must act before the next development milestone? Vivanti helps life sciences teams translate complex scientific, procedural and regulated information into structured digital content, role-specific learning and practical decision support. That can include internal communications, interactive evidence content, learning, simulations and materials that help teams apply a decision consistently rather than merely acknowledge that it was made. 🔄 Scientific advice creates its full value when the organisation stops operating from the previous version of the truth. Reflection: Which materials in your organisation would still be wrong tomorrow if today’s regulatory advice changed a core development assumption? #ScientificAdvice #RegulatoryStrategy #EvidenceGeneration #PharmaRD #MedicalCommunication